Status:
RECRUITING
HPV-based Screening Among Women 23-29 Years of Age
Lead Sponsor:
Karolinska Institutet
Conditions:
Human Papilloma Virus
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
23-29 years
Phase:
NA
Brief Summary
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
Detailed Description
The aim is to investigate whether primary HPV analysis in the organized cell sampling program for women in the age group 23-29 provides higher cancer protection compared to the current method where ce...
Eligibility Criteria
Inclusion
- Women ages 23-29 invited to screening.
Exclusion
- Women who do not show up for screening or do not consent.
Key Trial Info
Start Date :
November 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2038
Estimated Enrollment :
180000 Patients enrolled
Trial Details
Trial ID
NCT05229679
Start Date
November 16 2020
End Date
December 31 2038
Last Update
March 19 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Region of Skåne
Lund, Skåne County, Sweden, 221 00
2
Region Stockholm
Stockholm, Sweden, 102 39